{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:42:59Z","timestamp":1790667779406,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Programme Hospitalier de la Recherche Clinique","award":["AON 10-216"],"award-info":[{"award-number":["AON 10-216"]}]},{"name":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie \u2013 R\u00e9animation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00134-018-5160-6","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T05:21:14Z","timestamp":1526361674000},"page":"598-605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury"],"prefix":"10.1007","volume":"44","author":[{"name":"On behalf of FROG-ICU investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Gayat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Hollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Deye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Vieillard-Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Chousterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Fran\u00e7ois","family":"Laterre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Guidet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Sonneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Lefrant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-C\u00e9line","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Resche-Rigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9788-5316","authenticated-orcid":false,"given":"Matthieu","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"5160_CR1","doi-asserted-by":"publisher","first-page":"34265","DOI":"10.1038\/srep34265","volume":"6","author":"S-Y Cheng","year":"2016","unstructured":"Cheng S-Y, Chou Y-H, Liao F-L et al (2016) Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury. Sci Rep 6:34265. \n                    https:\/\/doi.org\/10.1038\/srep34265","journal-title":"Sci Rep"},{"key":"5160_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/ndt\/gfr256","volume":"27","author":"S Efrati","year":"2012","unstructured":"Efrati S, Berman S, Hamad RA et al (2012) Effect of captopril treatment on recuperation from ischemia\/reperfusion-induced acute renal injury. Nephrol Dial Transplant 27:136\u2013145. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfr256","journal-title":"Nephrol Dial Transplant"},{"key":"5160_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1113\/expphysiol.2011.063156","volume":"97","author":"LM Burrell","year":"2012","unstructured":"Burrell LM, Burchill L, Dean RG et al (2012) Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition. Exp Physiol 97:477\u2013485. \n                    https:\/\/doi.org\/10.1113\/expphysiol.2011.063156","journal-title":"Exp Physiol"},{"key":"5160_CR4","doi-asserted-by":"publisher","first-page":"46518","DOI":"10.1038\/srep46518","volume":"7","author":"Y-H Chou","year":"2017","unstructured":"Chou Y-H, Huang T-M, Pan S-Y et al (2017) Renin-angiotensin system inhibitor is associated with lower risk of ensuing chronic kidney disease after functional recovery from acute kidney injury. Sci Rep 7:46518. \n                    https:\/\/doi.org\/10.1038\/srep46518","journal-title":"Sci Rep"},{"key":"5160_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/CCM.0000000000000706","volume":"43","author":"CM Horkan","year":"2015","unstructured":"Horkan CM, Purtle SW, Mendu ML et al (2015) The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study. Crit Care Med 43:354\u2013364. \n                    https:\/\/doi.org\/10.1097\/CCM.0000000000000706","journal-title":"Crit Care Med"},{"key":"5160_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.07.007","author":"SK Parr","year":"2017","unstructured":"Parr SK, Matheny ME, Abdel-Kader K et al (2017) Acute kidney injury is a risk factor for subsequent proteinuria. Kidney Int. \n                    https:\/\/doi.org\/10.1016\/j.kint.2017.07.007","journal-title":"Kidney Int"},{"key":"5160_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12882-016-0430-4","volume":"18","author":"S Sawhney","year":"2017","unstructured":"Sawhney S, Marks A, Fluck N et al (2017) Acute kidney injury as an independent risk factor for unplanned 90-day hospital readmissions. BMC Nephrol 18:9. \n                    https:\/\/doi.org\/10.1186\/s12882-016-0430-4","journal-title":"BMC Nephrol"},{"key":"5160_CR8","doi-asserted-by":"publisher","first-page":"F943","DOI":"10.1152\/ajprenal.00183.2015","volume":"309","author":"I Rana","year":"2015","unstructured":"Rana I, Velkoska E, Patel SK et al (2015) MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injury. Am J Physiol Renal Physiol 309:F943\u2013F954. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00183.2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"5160_CR9","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.jacc.2016.01.050","volume":"67","author":"M Evans","year":"2016","unstructured":"Evans M, Carrero J-J, Szummer K et al (2016) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction. J Am Coll Cardiol 67:1687\u20131697. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2016.01.050","journal-title":"J Am Coll Cardiol"},{"key":"5160_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1113\/expphysiol.2007.040386","volume":"93","author":"L Burchill","year":"2008","unstructured":"Burchill L, Velkoska E, Dean RG et al (2008) Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Exp Physiol 93:622\u2013630. \n                    https:\/\/doi.org\/10.1113\/expphysiol.2007.040386","journal-title":"Exp Physiol"},{"key":"5160_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00134-017-4832-y","volume":"43","author":"M Joannidis","year":"2017","unstructured":"Joannidis M, Druml W, Forni LG et al (2017) Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. Intensive Care Med 43:730\u2013749. \n                    https:\/\/doi.org\/10.1007\/s00134-017-4832-y","journal-title":"Intensive Care Med"},{"key":"5160_CR12","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ndt\/gfv023","volume":"30","author":"W Cheungpasitporn","year":"2015","unstructured":"Cheungpasitporn W, Thongprayoon C, Srivali N et al (2015) Preoperative renin-angiotensin system inhibitors use linked to reduced acute kidney injury: a systematic review and meta-analysis. Nephrol Dial Transplant 30:978\u2013988. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfv023","journal-title":"Nephrol Dial Transplant"},{"key":"5160_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13054-017-1922-8","volume":"22","author":"E Gayat","year":"2018","unstructured":"Gayat E, Cariou A, Deye N et al (2018) Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study. Crit Care Lond Engl 22:8. \n                    https:\/\/doi.org\/10.1186\/s13054-017-1922-8","journal-title":"Crit Care Lond Engl"},{"key":"5160_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12871-015-0129-2","volume":"15","author":"A Mebazaa","year":"2015","unstructured":"Mebazaa A, Casadio MC, Azoulay E et al (2015) Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study. BMC Anesthesiol 15:143. \n                    https:\/\/doi.org\/10.1186\/s12871-015-0129-2","journal-title":"BMC Anesthesiol"},{"key":"5160_CR15","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EAJ Hoste","year":"2015","unstructured":"Hoste EAJ, Bagshaw SM, Bellomo R et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411\u20131423. \n                    https:\/\/doi.org\/10.1007\/s00134-015-3934-7","journal-title":"Intensive Care Med"},{"key":"5160_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00134-017-4809-x","volume":"43","author":"LG Forni","year":"2017","unstructured":"Forni LG, Darmon M, Ostermann M et al (2017) Renal recovery after acute kidney injury. Intensive Care Med 43:855\u2013866. \n                    https:\/\/doi.org\/10.1007\/s00134-017-4809-x","journal-title":"Intensive Care Med"},{"key":"5160_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"P Grambsch","year":"1994","unstructured":"Grambsch P, Therneau T (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515\u2013526","journal-title":"Biometrika"},{"key":"5160_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361\u2013387. \n                    https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19960229)15:4%3c361:AID-SIM168%3e3.0.CO;2-4","journal-title":"Stat Med"},{"key":"5160_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2017.17687","volume":"319","author":"HC Prescott","year":"2018","unstructured":"Prescott HC, Angus DC (2018) Enhancing recovery from sepsis: a review. JAMA 319:62\u201375. \n                    https:\/\/doi.org\/10.1001\/jama.2017.17687","journal-title":"JAMA"},{"key":"5160_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000476077","volume":"137","author":"F D\u00e9pret","year":"2017","unstructured":"D\u00e9pret F, Prud\u2019homme M, Legrand M (2017) A role of remote organs effect in acute kidney injury outcome. Nephron 137:273\u2013276. \n                    https:\/\/doi.org\/10.1159\/000476077","journal-title":"Nephron"},{"key":"5160_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.phrs.2016.03.018","volume":"107","author":"E Sim\u00f5es","year":"2016","unstructured":"Sim\u00f5es E, Silva AC, Teixeira MM (2016) ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res 107:154\u2013162. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2016.03.018","journal-title":"Pharmacol Res"},{"key":"5160_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","volume":"122","author":"J Zhong","year":"2010","unstructured":"Zhong J, Basu R, Guo D et al (2010) Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 122:717\u2013728. \n                    https:\/\/doi.org\/10.1161\/circulationaha.110.955369\n                    \n                   (18 p following 728)","journal-title":"Circulation"},{"key":"5160_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000065","author":"PK Whelton","year":"2017","unstructured":"Whelton PK, Carey RM, Aronow WS et al (2017) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Hypertens Dallas Tex. \n                    https:\/\/doi.org\/10.1161\/HYP.0000000000000065","journal-title":"Hypertens Dallas Tex"},{"key":"5160_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Eggers PW, Star RA, Kimmel PL (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371:58\u201366. \n                    https:\/\/doi.org\/10.1056\/NEJMra1214243","journal-title":"N Engl J Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00134-018-5160-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-018-5160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-018-5160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:54:16Z","timestamp":1557863656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00134-018-5160-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["5160"],"URL":"https:\/\/doi.org\/10.1007\/s00134-018-5160-6","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"26 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Complaince with ethical standards"}},{"value":"EG received research grants from Sphingotec, and consultancy fees from Magnisense and Roche Diagnostics. AM received speaker\u2019s honoraria from Abbott, Novartis, Orion, Roche and Servier, and fees as a member of the advisory board and\/or Steering Committee from Cardiorentis, Adrenomed, MyCartis, Neurotronik and Sphyngotec. ML received research grants from Sphingotec, consultancy fees from Astellas and Lecture fees from Gilead and Fresenius. The remaining authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}